Consultancy
Educational Activities
Building understanding of rare and metabolic disease
Overview
Rare disease and metabolic ageing are specialist fields, and the gap between what the science shows and what clinicians, patients, researchers and industry teams outside that specialism know can slow everything from diagnosis to trial design. CortexBio runs educational programmes that close that gap — turning complex, fast-moving science into practical understanding for the people who need to act on it.
What we do
- Workshops and symposia — expert-led sessions on emerging topics in rare disease and metabolic health.
- Training programmes — customised training for clinicians, researchers and industry teams.
- Educational resources — accessible materials explaining complex mechanisms and therapies.
- Knowledge translation — scientific discoveries turned into practical information for every stakeholder.
Where this creates value
A clinician who recognises the pattern of a rare metabolic disease earlier gets a patient to diagnosis faster. A trial team that understands the disease biology in plain terms designs better endpoints. A patient community that understands its own condition engages more confidently with research and treatment decisions. Educational activities are not a marketing exercise — they are the mechanism by which specialist knowledge, often locked in dense literature, becomes usable by the people whose decisions depend on it.
Why CortexBio
Dima Martini-Drew, MD, has spent 30 years translating rare disease science into practice at Genzyme, Astellas and Abbott, and has written and published on ageing and rare metabolic disease with registered, citable output. That same translation discipline — taking dense mechanism and making it usable without losing what matters — shapes every workshop, training programme and resource CortexBio produces.
Who this is for
Clinical teams who need to recognise rare metabolic disease patterns earlier, industry teams building internal fluency in rare disease or longevity biology, patient organisations supporting newly diagnosed families, and research groups who need dense literature translated for a non-specialist stakeholder — a funder, a regulator, or a patient advisory board.
Frequently asked questions
Who are CortexBio's educational programmes designed for?
Clinicians, researchers, patients and industry teams who need a working understanding of rare and metabolic disease science, whether for diagnosis, drug development or patient care — programmes are tailored to the audience's role and starting knowledge.
What formats do the educational activities take?
Workshops and symposia, customised training programmes, written educational resources, and knowledge translation work that converts primary research into practical, usable information.
How does this connect to CortexBio's other consultancy work?
Educational activities draw on the same clinical and scientific grounding as CortexBio's rare disease and longevity consultancy — the metabolic mosaic framework that connects rare disease and ageing biology underpins the training content as much as it underpins the strategic advice.
Can CortexBio build a bespoke training programme for our team?
Yes — training is customised to the audience, the disease area and the level of prior knowledge, rather than delivered as a generic course.
Do the educational resources require prior specialist knowledge?
No — materials are built for the audience they are written for, from clinician-level technical content through to plain-English explainers for patients and the public. The starting point is agreed before the material is written, not assumed.
Are educational activities delivered in person or online?
Both, depending on the audience and format — workshops and symposia can run in person or as live online sessions, and written resources are built to work as standalone reference material either way. The format is chosen to fit how the audience will actually use it, not defaulted to one channel.
How an engagement works
Educational programmes typically start with a short scoping conversation about the audience — their existing knowledge, what decisions or actions the training needs to support, and the format that will actually reach them, whether that is a live workshop, a written resource, or a structured multi-session programme. Content is then built specifically for that audience rather than adapted from a generic deck, and where the subject touches CortexBio's own published research, the material is grounded in that citable evidence rather than secondary summary.
For recurring needs — an industry team onboarding new starters into rare disease, or a patient organisation supporting newly diagnosed families — programmes can be structured to run on a regular cycle rather than as a one-off session.